JORDAN KRISTEN G,LETCHWORTH SHARON RAE,BENCHERIF MEROUANE
申请号：
NZ59673410
公开号：
NZ596734A
申请日:
2010.06.15
申请国别(地区):
NZ
年份:
2014
代理人:
摘要：
596734 Disclosed is the use of a compound which selectively targets both &alpha4&bgr2* and &alpha6&bgr2* for the manufacture of a medicament for treating, reducing, or delaying progression of L-dopa-induced dyskinesia or abnormal involuntary movements. Further disclosed is a combination comprising: a. L-dopa and b. one or more compound, which selectively targets both &alpha4&bgr2* and &alpha6&bgr2*.
